Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Maxwell Finland

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Living Beings

Geographic Areas

Boston

Physiology

Procedures

Microbial Sensitivity Tests

Disorders

Cross Infection

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
11
Eickhoff, Theodore
10
McGowan, John
4
Burke, John
2
Kirby, William
1
Shurin, Paul
1
Craven, Donald

Sign-in to see all Coauthors

Publications

TOP 3
Kass Edward H; Finland Maxwell
Asymptomatic infections of the urinary tract.
Barry M A; Craven D E; Finland M
Serotypes of Streptococcus pneumoniae isolated from blood cultures at Boston City Hospital between 1979 and 1982.
Finland M; Strauss E; Peterson O L
Landmark article June 14, 1941: Sulfadiazine. Therapeutic evaluation and toxic effects on four hundred and forty-six patients. By Maxwell Finland, Elias Strauss, and Osler L. Peterson.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Maxwell Finland (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2002: Kass Edward H; Finland Maxwell
Asymptomatic infections of the urinary tract.
The Journal of urology 2002;168(2):420-4.
1984: Barry M A; Craven D E; Finland M
Serotypes of Streptococcus pneumoniae isolated from blood cultures at Boston City Hospital between 1979 and 1982.
The Journal of infectious diseases 1984;149(3):449-52.
1984: Finland M; Strauss E; Peterson O L
Landmark article June 14, 1941: Sulfadiazine. Therapeutic evaluation and toxic effects on four hundred and forty-six patients. By Maxwell Finland, Elias Strauss, and Osler L. Peterson.
JAMA : the journal of the American Medical Association 1984;251(11):1467-74.
1983: Finland M
Empiric therapy for bacterial infections: the historical perspective.
Reviews of infectious diseases 1983;5 Suppl 1():S2-8.
1982: Finland M
Gaps in therapy for infectious diseases: a historical perspective.
The Journal of infectious diseases 1982;145(3):401-7.
1982: Finland M
Doting: my early experiences at Boston City Hospital.
The Pharos of Alpha Omega Alpha-Honor Medical Society. Alpha Omega Alpha 1982;45(3):17-22.
1981: Finland M
Conference on the Pneumococcus: summary and comments.
Reviews of infectious diseases 1981;3(2):358-71.
1981: Berk S L; Rice P A; Reynholds C A; Finland M
Pneumococcal pericarditis: a persisting problem in contemporary diagnosis.
The American journal of medicine 1981;70(2):247-51.
1979: Finland M
Pneumonia and pneumococcal infections, with special reference to pneumococcal pneumonia. The 1979 J. Burns Amberson lecture.
The American review of respiratory disease 1979;120(3):481-502.
1979: Finland M
Legionnaires' disease: they came, saw, and conquered.
Annals of internal medicine 1979;90(4):710-3.
1979: Finland M
Infectious Diseases Society of America. Presentation of the Bristol Award to Louis Weinstein.
The Journal of infectious diseases 1979;139(2):253-4.
1979: Finland M
Emergence of antibiotic resistance in hospitals, 1935-1975.
Reviews of infectious diseases 1979;1(1):4-22.
1978: Finland M; Barnes M W
Bacteremic superinfections of patients with bacteremia: occurrence, bacteriology, mortality, and duration of hospitalization at Boston City Hospital during 12 selected years between 1935 and 1972.
The Journal of infectious diseases 1978;138(6):829-36.
1978: Finland M; Barnes M W
Duration of hospitalization for bacteremic infections at Boston City Hospital during 12 selected years between 1935 and 1972.
The Journal of infectious diseases 1978;138(6):837-48.
1978: Finland M
New developments in antibiotics. Future clinical studies for the National Institute of Allergy and Infectious Diseases.
Annals of internal medicine 1978;89(5 Pt 2 Suppl):849-53.
1978: Finland M; Barnes M W
Duration of hospitalization for acute bacterial empyema at Boston City Hospital during 12 selected years from 1935 to 1972.
The Journal of infectious diseases 1978;138(4):520-30.
1978: Finland M
And the walls come tumbling down. More antibiotic resistance, and now the pneumococcus.
The New England journal of medicine 1978;299(14):770-1.
1978: Finland M; Barnes M W
Changing ecology of acute bacterial empyema: occurrence and mortality at Boston City Hospital during 12 selected years from 1935 to 1972.
The Journal of infectious diseases 1978;137(3):274-91.
1978: Finland M
Future developments of chemotherapy.
Infection 1978;6(5):202-3.
1978: Finland M
Acceptance of the George M. Kober medal for 1978.
Transactions of the Association of American Physicians 1978;91():63-71.
1977: Pelton S I; Shurin P A; Klein J O; Finland M
Quantitative inhibition of Haemophilus influenzae by trimethoprim/sulfamethoxazole.
Antimicrobial agents and chemotherapy 1977;12(6):649-54.
1977: Finland M; Barnes M W
Acute bacterial meningitis at Boston City Hospital during 12 selected years, 1935-1972.
The Journal of infectious diseases 1977;136(3):400-15.
1977: Finland M; Barnes M W
Duration of hospitalization for acute bacterial meningitis at Boston City Hospital during 12 selected years, 1935-1972.
The American journal of the medical sciences 1977;274(1):4-12.
1977: Sackel S G; Alpert S; Rosner B; McCormack W M; Finland M
In vitro activity of p-hydroxybenzyl penicillin (penicillin X) and five other penicillins against Neisseria gonorrhoeae: comparisons of strains from patients with uncomplicated infections and from women with pelvic inflammatory disease.
Antimicrobial agents and chemotherapy 1977;12(1):31-6.
1977: Finland M
Nosocomial epidemics seriatim. Multidrug-resistant bacteria and R factors.
Archives of internal medicine 1977;137(5):585-7.
1977: Finland M; Barnes M W
Changes in occurrence of capsular serotypes of Streptococcus pneumoniae at Boston City Hospital during selected years between 1935 and 1974.
Journal of clinical microbiology 1977;5(2):154-66.
1976: Finland M; Garner C; Wilcox C; Sabath L D
Susceptibility of recently isolated bacteria to amikacin in vitro: comparisons with four other aminoglycoside antibiotics.
The Journal of infectious diseases 1976;134 SUPPL():S297-307.
1976: Finland M; Garner C; Wilcox C; Sabath L D
Susceptibility of "enterobacteria" to penicillins, cephalosporins, lincomycins, erythromycin, and rifampin.
The Journal of infectious diseases 1976;134 Suppl():S75-96.
1976: Finland M; Garner C; Wilcox C; Sabath L D
Susceptibility of "enterobacteria" to aminoglycoside antibiotics: comparisons with tetracyclines, polymyxins, chloramphenicol, and spectinomycin.
The Journal of infectious diseases 1976;134 Suppl():S57-74.
1976: Sabath L D; Garner C; Wilcox C; Finland M
Susceptibility of Staphylococcus aureus and Staphylococcus epidermidis to 65 antibiotics.
Antimicrobial agents and chemotherapy 1976;9(6):962-9.
1976: McCormack W M; Finland M
Drugs five years later. Spectinomycin.
Annals of internal medicine 1976;84(6):712-6.
1976: Baltimore R S; Klein J O; Wilcox C; Finland M
Synergy of mecillinam (FL1060) with penicillins and cephalosporins against Proteus and Klebsiella, with observations on combinations with other antibiotics and against other bacterial species.
Antimicrobial agents and chemotherapy 1976;9(4):701-5.
1976: Finland M; Garner C; Wilcox C; Sabath L D
Susceptibility of Neisseria gonorrhoeae to 66 antibacterial agents in vitro.
Journal of the American Venereal Disease Association 1976;2(3):33-40.
1976: Finland M; McGowan J E
Nosocomial infections in surgical patients. Observations on effects of prophylactic antibiotics.
Archives of surgery (Chicago, Ill. : 1960) 1976;111(2):143-5.
1976: McGowan J E; Finland M
Effects of monitoring the usage of antibiotics: an interhospital comparison.
Southern medical journal 1976;69(2):193-5.
1976: Finland M; Garner C; Wilcox C; Sabath L D
Susceptibility of pneumococci and Haemophilus influenzae to antibacterial agents.
Antimicrobial agents and chemotherapy 1976;9(2):274-87.
1976: Finland M; Garner C; Wilcox C; Sabath L D
Susceptibility of beta-hemolytic streptococci to 65 antibacterial agents.
Antimicrobial agents and chemotherapy 1976;9(1):11-9.
1976: Finland M; Barnes M W
Changing etiology of bacterial infections.
Antibiotics and chemotherapy 1976;21():170-5.
1975: Sabath L D; Garner C; Wilcox C; Finland M
Effect of inoculum and of beta-lactamase on the anti-staphylococcal activity of thirteen penicillins and cephalosporins.
Antimicrobial agents and chemotherapy 1975;8(3):344-9.
1975: McGowan J E; Barnes M W; Finland M
Bacteremia at Boston City Hospital: Occurrence and mortality during 12 selected years (1935-1972), with special reference to hospital-acquired cases.
The Journal of infectious diseases 1975;132(3):316-35.
1975: Garner C; Rosner B; Finland M
Disk diffusion and serial dilution tests of susceptibility of some pathogenic gram-negative bacilli and enterococci to carbenicillin and ampicillin.
Antimicrobial agents and chemotherapy 1975;8(2):172-86.
1975: Finland M
Editorial: The present and future of clinical research in infectious diseases.
The Journal of laboratory and clinical medicine 1975;86(1):1-6.
1975: Finland M
Relationships of antibiotics in animal feeds and salmonellosis in animals and man.
Journal of animal science 1975;40(6):1222-40.
1974: Finland M
Antimicrobial drugs.
Clinical pharmacology and therapeutics 1974;16(5 Part 2):914-8.
1974: Finland M
Editorial: Combinations of antimicrobial drugs: trimethoprim-sulfamethoxazole.
The New England journal of medicine 1974;291(12):624-7.
1974: Finland M
Letter: Antibiotic-supplemented feeds.
JAMA : the journal of the American Medical Association 1974;229(13):1723-4.
1974: Finland M; Garner C; Wilcox C; Sabath L D
Salmonellosis and shigellosis at Boston City Hospital. 2. Susceptibility of strains of Salmonellae and Shigellae to antibacterial agents.
JAMA : the journal of the American Medical Association 1974;229(10):1309-12.
1974: McGowan J E; Finland M
Usage of antibiotics in a general hospital: effect of requiring justification.
The Journal of infectious diseases 1974;130(2):165-8.
1974: Finland M; Barnes M W
Salmonellosis and shigellosis at Boston City Hospital. 1. Relationship to bacteremic infections due to enterobacteria.
JAMA : the journal of the American Medical Association 1974;229(9):1183-6.
1974: McGowan J E; Garner C; Wilcox C; Finland M
Antibiotic susceptibility of gram-negative bacilli isolated from blood cultures. Results of tests with 35 agents and strains from 169 patients at Boston City Hospital during 1972.
The American journal of medicine 1974;57(2):225-38.
1974: McGowan J E; Klein J O; Bratton L; Barnes M W; Finland M
Meningitis and bacteremia due to Haemophilus influenzae: occurrence and mortality at Boston City Hospital in 12 selected years, 1935-1972.
The Journal of infectious diseases 1974;130(2):119-24.
1974: Finland M; McGowan J E; Garner C; Wilcox C
Amoxicillin: in vitro susceptibility of "blood culture strains" of gram-negative bacilli and comparisons with penicillin G ampicillin, and carbenicillin.
The Journal of infectious diseases 1974;129(0):suppl:S132-8.
1974: McGowan J E; Finland M
Infection and antibiotic usage at Boston City Hospital: changes in prevalence during the decade 1964-1973.
The Journal of infectious diseases 1974;129(4):421-8.
1974: Finland M; Bach M C; Garner C; Gold O
Synergistic action of ampicillin and erythromycin against Nocardia asteroides: effect of time of incubation.
Antimicrobial agents and chemotherapy 1974;5(3):344-53.
1974: McGowan J E; Barnes M W; Finland M
Host-pathogen-drug interactions in surgical patients with bacteremia.
Surgery, gynecology & obstetrics 1974;138(1):50-4.
1974: Finland M
Twenty-fifth anniversary of the discovery of Aureomycin: the place of the tetracyclines in antimicrobial therapy.
Clinical pharmacology and therapeutics 1974;15(1):3-8.
1973: Finland M; Kass E H
Trimethoprim-sulfamethoxazole. Summary and comments on the conference.
The Journal of infectious diseases 1973;128():Suppl:792-816.
1973: Bach M C; Gold O; Finland M
Absorption and urinary execretion of trimethoprim, sulfamethoxazole, and trimethoprim-sulfamethoxazole: results with single doses in normal young adults and preliminary observations during therapy with trimethoprim-sulfamethoxazole.
The Journal of infectious diseases 1973;128():Suppl:584-99 p.
1973: Lewin E B; Klein J O; Finland M
Trimethoprim-sulfamethoxazole: absorption, excretion, and toxicity in six children.
The Journal of infectious diseases 1973;128():Suppl:618-21 p.
1973: Bach M C; Finland M; Gold O; Wilcox C
Susceptibility of recently isolated pathogenic bacteria to trimethoprim and sulfamethoxazole separately and combined.
The Journal of infectious diseases 1973;128():Suppl:508-33 p.
1973: Sabath L D; Wilcox C; Garner C; Finland M
In vitro activity of cefazolin against recent clinical bacterial isolates.
The Journal of infectious diseases 1973;128():Suppl:S320-6.
1973: Finland M
Superinfections in the antibiotic era.
Postgraduate medicine 1973;54(4):175-83.
1973: Finland M
Excursions into epidemiology: selected studies during the past four decades at Boston City Hospital.
The Journal of infectious diseases 1973;128(1):76-124.
1973: Bach M C; Monaco A P; Finland M
Pulmonary nocardiosis. Therapy with minocycline and with erythromycin plus ampicillin.
JAMA : the journal of the American Medical Association 1973;224(10):1378-81.
1973: McGowan J E; Bratton L; Klein J O; Finland M
Bacteremia in febrile children seen in a "walk-in" pediatric clinic.
The New England journal of medicine 1973;288(25):1309-12.
1973: Bach M C; Gold O; Finland M
Activity of minocycline against Nocardia asteroides: comparison with tetracycline in agar-dilution and standard disc-diffusion tests and with sulfadiazine in an experimental infection of mice.
The Journal of laboratory and clinical medicine 1973;81(5):787-93.
1973: Bach M C; Sabath L D; Finland M
Susceptibility of Nocardia asteroides to 45 antimicrobial agents in vitro.
Antimicrobial agents and chemotherapy 1973;3(1):1-8.
1972: Finland M
Antifungal activity of flucytosine.
Archives of internal medicine 1972;130(5):789-90.
1972: Finland M
Current problems in infective endocarditis. With special reference to cases acquired in hospital or after cardiac surgery.
Modern concepts of cardiovascular disease 1972;41(11):53-8.
1972: O'Riordan C; Adler J L; Banks H H; Finland M
A prospective study of wound infections on an orthopedic service with illustrative cases.
Clinical orthopaedics and related research 1972;87():188-91.
1972: Finland M
Global epidemiology - stocktaking at WHO.
The New England journal of medicine 1972;287(11):565-6.
1972: Finland M
Perspective. Hospital-acquired infections: the problems of methicillin-resistant Staphylococcus aureus and infections with Klebsiella pneumoniae.
The American journal of the medical sciences 1972;264(3):207-11.
1972: Finland M
Adventures with antibacterial drugs.
Clinical pharmacology and therapeutics 1972;13(4):469-511.
1972: Finland M
Changing patterns of susceptibility of common bacterial pathogens to antimicrobial agents.
Annals of internal medicine 1972;76(6):1009-36.
1972: O'Riordan C; Adler J L; Banks H H; Finland M
Wound infections on an orthopedic service. A prospective study.
American journal of epidemiology 1972;95(5):442-50.
1972: Bach M C; Zinner S H; Wilcox C; Finland M
Efficacy of standard disc-diffusion test as applied to susceptibility of Staphylococcus aureus to tetracycline and minocycline.
The Journal of laboratory and clinical medicine 1972;79(2):316-25.
1972: Finland M
Oral and parenteral cephalosporins: the place of cephalexin in antibacterial therapy.
Drugs 1972;3(1):1-8.
1972: Finland M
Edwin Allen Locke 1874-1971.
Transactions of the Association of American Physicians 1972;85():27-30.
1971: Finland M
Antibiotic combinations.
Delaware medical journal 1971;43(11):296-301.
1971: Adler J L; Finland M
Susceptibility of recent isolates of Pseudomonas aeruginosa to gentamicin, polymyxin, and five penicillins, with observations on the pyocin and immunotypes of the strains.
Applied microbiology 1971;22(5):870-5.
1971: Adler J L; Burke J P; Martin D F; Finland M
Proteus infections in a general hospital. I. Biochemical characteristics and antibiotic susceptibility of the organisms. With special reference to proticine typing and the Dienes phenomenon.
Annals of internal medicine 1971;75(4):517-30.
1971: Adler J L; Burke J P; Martin D F; Finland M
Proteus infections in a general hospital. II. Some clinical and epidemiological characteristis. With an analysis of 71 cases of proteus bacteremia.
Annals of internal medicine 1971;75(4):531-6.
1971: Sabath L D; Casey J I; Ruch P A; Stumpf L L; Finland M
Rapid microassay of gentamicin, kanamycin, neomycin, streptomycin, and vancomycin in serum or plasma.
The Journal of laboratory and clinical medicine 1971;78(3):457-63.
1971: Finland M
I. Prevalence of extrachromosomal drug resistance. Changes in asusceptibility of selected pathogenic bacteria to widely used antibiotics.
Annals of the New York Academy of Sciences 1971;182():5-20.
1971: Zinner S H; Sabath L D; Casey J I; Finland M
Erythromycin and alkalinisation of urine in the treatment of urinary-tract infections due to gram-negative bacilli.
Lancet 1971;1(7712):1267-8.
1971: Krey P R; Cohen A S; Smith C B; Finland M
The human fetal synovium. Histology, fine structure and changes in organ culture.
Arthritis and rheumatism 1971;14(3):319-41.
1971: Burke J P; Klein J O; Gezon H M; Finland M
Pneumococcal bacteremia. Review of 111 cases, 1957--1969, with special reference to cases with undetermined focus.
American journal of diseases of children (1960) 1971;121(4):353-9.
1971: Adler J L; Burke J P; Finland M
Infection and antibiotic usage at Boston City Hospital, January 1970.
Archives of internal medicine 1971;127(3):460-5.
1971: Burke J P; Ingall D; Klein J O; Gezon H M; Finland M
Proteus mirabilis infections in a hospital nursery traced to a human carrier.
The New England journal of medicine 1971;284(3):115-21.
1971: Finland M
Increased resistance in the pneumococcus.
The New England journal of medicine 1971;284(4):212-4.
1970: Toala P; Schroeder S A; Daly A K; Finland M
Candida at Boston City Hospital. Clinical and epidemiological characteristics and susceptibility to eight antimicrobial agents.
Archives of internal medicine 1970;126(6):983-9.
1970: Schroeder S A; Catino D; Toala P; Finland M
Chronic pseudomonas osteomyelitis. Report on the use of gentamicin sulphate in three cases.
The Journal of bone and joint surgery. American volume 1970;52(8):1611-7.
1970: Finland M
Changing ecology of bacterial infections as related to antibacterial therapy.
The Journal of infectious diseases 1970;122(5):419-31.
1970: Smith C B; Wilfert J N; Dans P E; Kurrus T A; Finland M
In-vitro activity of carbenicillin and results of treatment of infections due to Pseudomonas with carbenicillin singly and in combination with gentamicin.
The Journal of infectious diseases 1970;122():Suppl:S14-28.
1970: Toala P; Lee Y H; Wilcox C; Finland M
Susceptibility of Enterobacter aerogenes and Enterobacter cloacae to 19 antimicrobial agents in vitro.
The American journal of the medical sciences 1970;260(1):41-55.
1970: Barrett F F; Casey J I; Wilcox C; Finland M
Bacteriophage types and antibiotic susceptibility of Staphylococcus aureus. Boston City Hospital, 1967.
Archives of internal medicine 1970;125(5):867-73.
1970: Toala P; Wilcox C; Finland M
Effect of pH of medium and size of inoculum on activity of antibiotics against group D Streptococcus (Enterococcus).
Applied microbiology 1970;19(4):629-37.
1970: Finland M
Revival of antibacterial immunization: meningococcal vaccines prove promising.
The Journal of infectious diseases 1970;121(4):445-8.
1970: Sabath L D; Gerstein D A; Leaf C D; Finland M
Increasing the usefulness of antibiotics: Treatment of infections caused by gram-negative bacilli.
Clinical pharmacology and therapeutics 1970;11(2):161-7.
1970: Sabath L D; Leaf C D; Gerstein D A; Finland M
Altered cell walls of Staphylococcus aureus resistant to methicillin.
Nature 1970;225(5237):1074.
1970: Finland M; Barnes M W
Changing etiology of bacterial endocarditis in the antibacterial era. Experiences at Boston City Hospital 1933-1965.
Annals of internal medicine 1970;72(3):341-8.
1970: Dans P E; McGehee R F; Wilcox C; Finland M
Rifampin: antibacterial activity in vitro and absorption and excretion in normal young men.
The American journal of the medical sciences 1970;259(2):120-32.
1970: Wilfert J N; Barrett F F; Ewing W H; Finland M; Kass E H
Serratia marcescens: biochemical, serological, and epidemiological characteristics and antibiotic susceptibility of strains isolated at Boston City Hospital.
Applied microbiology 1970;19(2):345-52.
1970: Dans P E; Barrett F F; Casey J I; Finland M
Klebsiella-Enterobacter at Boston City Hospital, 1967.
Archives of internal medicine 1970;125(1):94-101.
1969: Toala P; McDonald A; Wilcox C; Finland M
Susceptibility of group D streptococcus (enterococcus) to 21 antibiotics in vitro, with special reference to species differences.
The American journal of the medical sciences 1969;258(6):416-30.
1969: Finland M
Gentamicin: antibacterial activity, clinical pharmacology and clinical applications.
Medical times 1969;97(12):161-74.
1969: Finland M
Clinical investigation of new antimicrobial agents.
The Journal of infectious diseases 1969;120(5):620-9.
1969: Finland M
Diagnostic lung puncture.
Pediatrics 1969;44(4):471-3.
1969: Tillotson J R; Finland M
Bacterial colonization and clinical superinfection of the respiratory tract complicating antibiotic treatment of pneumonia.
The Journal of infectious diseases 1969;119(6):597-624.
1969: Castle W B; Astwood E B; Finland M; Keefer C S
White paper on the therapeutic equivalence of chemically equivalent drugs.
JAMA : the journal of the American Medical Association 1969;208(7):1171-2.
1969: Klein J O; Buckland D; Finland M
Colonization of newborn infants by mycoplasmas.
The New England journal of medicine 1969;280(19):1025-30.
1969: Finland M
The symposium on gentamicin.
The Journal of infectious diseases 1969;119(4):537-40.
1969: Smith C B; Dans P E; Wilfert J N; Finland M
Use of gentamicin in combinations with other antibiotics.
The Journal of infectious diseases 1969;119(4):370-7.
1969: McCall C E; Katayama I; Cotran R S; Finland M
Lysosomal and ultrastructural changes in human "toxic" neutrophils during bacterial infection.
The Journal of experimental medicine 1969;129(2):267-93.
1969: Lorian V; Finland M
In vitro effect of rifampin on mycobacteria.
Applied microbiology 1969;17(2):202-7.
1969: Klein J O; Green G M; Tilles J G; Kass E H; Finland M
Effect of intranasal reovirus infection on antibacterial activity of mouse lung.
The Journal of infectious diseases 1969;119(1):43-50.
1968: Sabath L D; Gerstein D A; Loder P B; Finland M
Excretion of erythromycin and its enhanced activity in urine against gram-negative bacilli with alkalinization.
The Journal of laboratory and clinical medicine 1968;72(6):916-23.
1968: Tilles J G; Finland M
Microassay for human and chick cell interferons.
Applied microbiology 1968;16(11):1706-7.
1968: Sabath L D; Gerstein D A; Finland M
Serum glutamic oxalacetic transaminase. False elevations during administration of erythromycin.
The New England journal of medicine 1968;279(21):1137-9.
1968: Smith C B; Finland M
Carbenicillin: activity in vitro and absorption and excretion in normal young men.
Applied microbiology 1968;16(11):1753-60.
1968: Braun P; Tillotson J R; Wilcox C; Finland M
Cephalexin and cephaloglycin activity in vitro and absorption and urinary excretion of single oral doses in normal young adults.
Applied microbiology 1968;16(11):1684-94.
1968: McGehee R F; Smith C B; Wilcox C; Finland M
Comparative studies of antibacterial activity in vitro and absorption and excretion of lincomycin and clinimycin.
The American journal of the medical sciences 1968;256(5):279-92.
1968: Sabath L D; Lorian V; Gerstein D; Loder P B; Finland M
Enhancing effect on alkalinization of the medium on the activity of erythromycin against gram-negative bacteria.
Applied microbiology 1968;16(9):1288-92.
1968: Barrett F F; McGehee R F; Finland M
Methicillin-resistant Staphylococcus aureus at Boston City Hospital. Bacteriologic and epidemiologic observations.
The New England journal of medicine 1968;279(9):441-8.
1968: Sabath L D; Loder P B; Gerstein D A; Finland M
Measurement of three antibiotics (penicillin, cephalothin, and chloramphenicol) when present together in mixtures.
Applied microbiology 1968;16(6):877-80.
1968: Steigbigel N H; Reed C W; Finland M
Absorption and excretion of five tetracycline analogues in normal young men.
The American journal of the medical sciences 1968;255():296-312.
1968: Sabath L D; Finland M
Thiol-group binding of zinc to a beta-lactamase of Bacillus cereus: differential effects on enzyme activity with penicillin and cephalosporins as substrates.
Journal of bacteriology 1968;95(5):1513-9.
1968: Steigbigel N H; Reed C W; Finland M
Susceptibility of common pathogenic bacteria to seven tetracycline antibiotics in vitro.
The American journal of the medical sciences 1968;255():179-95.
1968: Steigbigel N H; Kislak J W; Tilles J G; Finland M
Clinical evaluation of cephaloridine.
Archives of internal medicine 1968;121(1):24-38.
1968: Barrett F F; Casey J I; Finland M
Infections and antibiotic use among patients at Boston City Hospital, February, 1967.
The New England journal of medicine 1968;278(1):5-9.
1967: Sabath L D; Finland M
Resistance of penicillins and cephalosporins to beta-lactamases from Gram-negative bacilli: some correlations with antibacterial activity.
Annals of the New York Academy of Sciences 1967;145(2):237-47.
1967: Tilles J G; Klein J O; Jao R L; Haslam J E; Feingold M; Gellis S S; Finland M
Acute otitis media in children. Serologic studies and attempts to isolate viruses and mycoplasmas from aspirated middle-ear fluids.
The New England journal of medicine 1967;277(12):613-8.
1967: Steigbigel N H; McCall C E; Reed C W; Finland M
Antibacterial action of "broad-spectrum" penicillins, cephalosporins and other antibiotics against Gram-negative bacilli isolated from bacteremic patients.
Annals of the New York Academy of Sciences 1967;145(2):224-36.
1967: Sabath L D; Elder H A; McCall C E; Finland M
Synergistic combinations of penicillins in the treatment of bacteriuria.
The New England journal of medicine 1967;277(5):232-8.
1967: McCall C E; Steigbigel N H; Finland M
Lincomycin: activity in vitro and absorption and excretion in normal young men.
The American journal of the medical sciences 1967;254(2):144-55.
1967: Sabath L D; Estey V J; Finland M
Independent measurement of ampicillin and cloxacillin in mixtures.
Applied microbiology 1967;15(3):468-70.
1966: Steinhauer B W; Eickhoff T C; Kislak J W; Finland M
The Klebsiella-Enterobacter-Serratia division. Clinical and epidemiologic characteristics.
Annals of internal medicine 1966;65(6):1180-94.
1966: Eickhoff T C; Steinhauer B W; Finland M
The Klebsiella-Enterobacter-Serratia division. Biochemical and serologic characteristics and susceptibility to antibiotics.
Annals of internal medicine 1966;65(6):1163-79.
1966: Finland M
Ethics, consent, and controlled clinical trial.
JAMA : the journal of the American Medical Association 1966;198(6):637-8.
1966: Mendelson J; Finland M
Effects of cortisol on interferon production by mouse peritoneal leukocytes and spleen in vitro and in vivo.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1966;123(1):98-104.
1966: Kislak J W; Steinhauer B W; Finland M
Cephaloridine activity in vitro and absorption and urinary excretion in normal young men.
The American journal of the medical sciences 1966;251(4):433-48.
1966: Feingold M; Klein J O; Haslam G E; Finland M; Gellis S S; Tilles J G
Acute otitis media in children. Bacteriological findings in middle ear fluid obtained by needle aspiration.
American journal of diseases of children (1960) 1966;111(4):361-5.
1966: Abramowicz M; Klein J O; Ingall D; Finland M
Levels of penicillin in serum of newborn infants.
American journal of diseases of children (1960) 1966;111(3):267-71.
1965: Kislak J W; Razavi L M; Daly A K; Finland M
Susceptibility of pneumococci to nine antibiotics.
The American journal of the medical sciences 1965;250(3):261-8.
1965: KISLAK J W; EICKHOFF T C; FINLAND M
CLOXACILLIN: ACTIVITY IN VITRO, AND ABSORPTION AND URINARY EXCRETION IN NORMAL YOUNG MEN.
The American journal of the medical sciences 1965;249():636-46.
1965: EICKHOFF T C; FINLAND M; WILCOX C
IN VITRO SUSCEPTIBILITY OF GROUP A BETA HEMOLYTIC STREPTOCOCCI TO 18 ANTIBIOTICS.
The American journal of the medical sciences 1965;249():261-8.
1965: EICKHOFF T C; FINLAND M
POLYMYXIN B AND COLISTIN: IN VITRO ACTIVITY AGAINST PSEUDOMONAS AERUGINOSA.
The American journal of the medical sciences 1965;249():172-4.
1965: EICKHOFF T C; KISLAK J W; FINLAND M
SODIUM AMPICILLIN: ABSORPTION AND EXCRETION OF INTRAMUSCULAR AND INTRAVENOUS DOSES IN NORMAL YOUNG MEN.
The American journal of the medical sciences 1965;249():163-71.
1965: FINLAND M
STAPHYLOCOCCAL INFECTIONS AND ANTISTAPHYLOCOCCAL ANTIBIOTICS.
Medical times 1965;93():101-14.
1965: EICKHOFF T C; FINLAND M
CHANGING SUSCEPTIBILITY OF MENINGOCOCCI TO ANTIMICROBIAL AGENTS.
The New England journal of medicine 1965;272():395-8.
1964: KLEIN J O; EICKHOFF T C; TILLES J G; FINLAND M
CEPHALOTHIN: ACTIVITY IN VITRO, ABSORPTION AND EXCRETION IN NORMAL SUBJECTS AND CLINICAL OBSERVATIONS IN 40 PATIENTS.
The American journal of the medical sciences 1964;248():640-56.
1964: TILLES J G; ELSON S H; SHAKA J A; ABELMANN W H; LERNER A M; FINLAND M
EFFECTS OF EXERCISE ON COXSACKIE A9 MYOCARDITIS IN ADULT MICE.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1964;117():777-82.
1964: EICKHOFF T C; KLEIN J O; DALY A K; INGALL D; FINLAND M
NEONATAL SEPSIS AND OTHER INFECTIONS DUE TO GROUP B BETA-HEMOLYTIC STREPTOCOCCI.
The New England journal of medicine 1964;271():1221-8.
1964: KLEIN J O; EICKHOFF T C; FINLAND M
GENTAMICIN: ACTIVITY IN VITRO AND OBSERVATIONS IN 26 PATIENTS.
The American journal of the medical sciences 1964;248():528-44.
1964: FINLAND M
THE TRAINING OF THE PHYSICIAN. THE HARVARD MEDICAL UNIT AT THE BOSTON CITY HOSPITAL--A PERSPECTIVE.
The New England journal of medicine 1964;271():1096-100.
1964: KISLAK J W; EICKHOFF T C; FINLAND M
HOSPITAL-ACQUIRED INFECTIONS AND ANTIBIOTIC USAGE IN THE BOSTON CITY HOSPITAL--JANUARY, 1964.
The New England journal of medicine 1964;271():834-5.
1963: REMINGTON J S; DALRYMPLE W; JACOBS L; FINLAND M
TOXOPLASMA ANTIBODIES AMONG COLLEGE STUDENTS.
The New England journal of medicine 1963;269():1394-8.
1963: KLEIN J O; SABATH L D; STEINHAUER B W; FINLAND M
OXACILLIN TREATMENT OF SEVERE STAPHYLOCOCCAL INFECTIONS.
The New England journal of medicine 1963;269():1215-25.
1963: KLEIN J O; FINLAND M
THE NEW PENICILLINS.
The New England journal of medicine 1963;269():1074-82 CONTD.
1963: KLEIN J O; FINLAND M
THE NEW PENICILLINS.
The New England journal of medicine 1963;268():1074-82 CONTD.
1963: KLEIN J O; FINLAND M
THE NEW PENICILINS.
The New England journal of medicine 1963;269():1019-25 CONTD.
1963: KLEIN J O; FINLAND M
THE NEW PENICILLINS.
The New England journal of medicine 1963;269():1129-34 CONCL.
1963: KLEIN J O; SABATH L D; STEINHAUER B W; FINLAND M
TREATMENT OF SEVERE STAPHYLOCOCCAL INFECTIONS WITH ANCILLIN.
The American journal of the medical sciences 1963;246():385-403.
1963: CHERRY J D; LERNER A M; KLEIN J O; FINLAND M
ECHO 11 VIRUS INFECTIONS ASSOCIATED WITH EXANTHEMS.
Pediatrics 1963;32():509-16.
1963: KJELLANDER J O; FINLAND M
PENICILLIN TREATMENT OF GONORRHEAL URETHRITIS. EFFECTS OF PENICILLIN SUSCEPTIBILITY OF CAUSATIVE ORGANISM AND CONCOMITANT PRESENCE OF PENICILLINASE- PRODUCING BACTERIA ON RESULTS.
The New England journal of medicine 1963;269():834-6.
1963: LERNER A M; KLEIN J O; CHERRY J D; FINLAND M
NEW VIRAL EXANTHEMS (CONCLUDED).
The New England journal of medicine 1963;269():736-40 CONCL.
1963: LERNER A M; KLEIN J O; CHERRY J D; FINLAND M
NEW VIRAL EXANTHEMS.
The New England journal of medicine 1963;269():678-85.
1963: KJELLANDER J O; FINLAND M
STUDIES ON THE PENICILLINASE OF STAPHYLOCOCCUS ALBUS.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1963;113():1031-7.
1963: KJELLANDER J O; KLEIN J O; FINLAND M
IN VITRO ACTIVITY OF PENICILLINS AGAINST STAPHYLOCOCCUS ALBUS.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1963;113():1023-31.
1963: SABATH L D; KLEIN J O; FINLAND M
ANCILLIN (2-BIPHENYLYLPENICILLIN): ANTIBACTERIAL ACTIVITY AND CLINICAL PHARMACOLOGY.
The American journal of the medical sciences 1963;246():129-46.
1963: MERLER E; REMINGTON J S; FINLAND M; GITLIN D
CHARACTERIZATION OF ANTIBODIES IN NORMAL HUMAN URINE.
The Journal of clinical investigation 1963;42():1340-52.
1963: KLEIN J O; FINLAND M
NAFCILLIN. ANTIBACTERIAL ACTION IN VITRO AND ABSORPTION AND EXCRETION IN NORMAL YOUNG MEN.
The American journal of the medical sciences 1963;246():10-26.
1963: KLEIN J O; FINLAND M
Ampicillin activity in vitro and absorption and excretion in normal young men.
The American journal of the medical sciences 1963;245():544-55.
1963: CHERRY J D; LERNER A M; KLEIN J O; FINLAND M
Coxsackie A9 infections with exanthems, with particular reference to urticaria.
Pediatrics 1963;31():819-23.
1963: KLEIN J O; SABATH L D; FINLAND M
Laboratory studies on oxacillin. I. In vitro activity against staphylococci and some other bacterial pathogens. II. Absorption and urinary excretion in normal young men.
The American journal of the medical sciences 1963;245():399-412.
1963: CHERRY J D; LERNER A M; KLEIN J O; FINLAND M
Coxsackie B5 infections with exanthems.
Pediatrics 1963;31():455-62.
1963: SABATH L D; STEINHAUER B W; FINLAND M
Combined action of penicillin G with methicillin or oxacillin against Staphylococcus aureus.
The New England journal of medicine 1963;268():284-6.
1963: SABATH L; FINLAND M
Inactivation of some semisynthetic penicillins by gram-negative bacilli.
Journal of bacteriology 1963;85():314-21.
1963: LERNER A M; CHERRY J D; FINLAND M
Hemagglutination with reoviruses.
Virology 1963;19():58-65.
1962: SABATH L D; FINLAND M
Inactivation of methicillin, oxacillin and ancillin by Staphylococcus aureus.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1962;111():547-50.
1962: MERLER E; REMINGTON J S; FINLAND M; GITLIN D
Differences between urinary albumin and serum albumin.
Nature 1962;196():1207-8.
1962: SABATH L D; POSTIC B; FINLAND M
Methicillin treatment of severe staphylococcal disease. Observations in 146 cases.
The New England journal of medicine 1962;267():1049-57.
1962: LERNER A M; CHERRY J D; KLEIN J O; FINLAND M
Infections with reoviruses.
The New England journal of medicine 1962;267():947-52.
1962: SABATH L D; POSTIC B; FINLAND M
Laboratory studies on methicillin. With special reference to patients treated for staphylococcal infections.
The American journal of the medical sciences 1962;244():484-500.
1962: LERNER A M; CHERRY J D; FINLAND M
Enhancement of cytopathic effects of reoviruses in rolled cultures of rhesus kidney.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1962;110():727-9.
1962: REMINGTON J S; FINLAND M
Antibacterial activity of serum after oral doses of tetracycline, demethylchlortetracycline, and 6-methyleneoxytetracycline.
Clinical pharmacology and therapeutics 1962;3():284-304.
1962: REMINGTON J S; MERLER E; LERNER A M; GITLIN D; FINLAND M
Antibodies of low molecular weight in normal human urine.
Nature 1962;194():407-8.
1962: LERNER A M; REMINGTON J S; FINLAND M
Neutralizing antibody to polioviruses in normal human urine.
The Journal of clinical investigation 1962;41():805-15.
1962: LERNER A M; LEVIN H S; FINLAND M
Age and susceptibility of mice to Coxsackie A viruses.
The Journal of experimental medicine 1962;115():745-62.
1962: SABATH L D; FINLAND M
Diffusion of penicillinase from Staphylococcus aureus.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1962;109():478-82.
1962: SABATH L D; FINLAND M
Sterile penicillinase from phagelysed staphylococci.
Nature 1962;193():272-3.
1962: BENNETT I L; FINLAND M; HAMBURGER M; KASS E H; LEPPER M; WAISBREN B A
A double-blind study of the effectiveness of cortisol in the management of severe infections.
Transactions of the Association of American Physicians 1962;75():198-207.
1961: POSTIC B; FINLAND M
Observations on bacteriophage typing of Pseudomonas aeruginosa.
The Journal of clinical investigation 1961;40():2064-75.
1961: POSTIC B; FINLAND M
In vitro susceptibility of recently isolated strains of Pseudomonas aeruginosa to ten antibiotics.
The American journal of the medical sciences 1961;242():551-9.
1961: WALLMARK G; FINLAND M
Studies on staphylococci of phage type "80/81".
The American journal of the medical sciences 1961;242():279-85.
1961: LERNER A M; FINLAND M
Coxsackie viral infections.
Archives of internal medicine 1961;108():329-34.
1961: REMINGTON J S; FINLAND M
Precipitating antibody in normal human urine.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1961;107():765-70.
1961: LERNER A M; REMINGTON J S; FINLAND M
Neutralizing antibody to polioviruses in normal human urine.
Virology 1961;14():383-5.
1961: FINLAND M
Infections in splenectomized children.
Pediatrics 1961;28():162-3.
1961: MCCARTHY C G; FINLAND M
Furaltadone. Antibacterial activity in vitro and in serum of patients during treatment.
Archives of internal medicine 1961;107():863-71.
1961: FINLAND M
Serious infections in splenectomized children.
Pediatrics 1961;27():689-91.
1961: WALLMARK G; FINLAND M
Phage types and antibiotic susceptibility of pathogenic staphylococci. Results at Boston City Hospital 1959-1960 and comparison with strains of previous years.
JAMA : the journal of the American Medical Association 1961;175():886-97.
1961: MCCARTHY C G; WALLMARK G; FINLAND M
In vitro activity of various penicillins.
The American journal of the medical sciences 1961;241():143-59.
1961: WALLMARK G; FINLAND M
New phages active against staphylococci that are resistant to the conventional phage set.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1961;106():73-8.
1961: WALLMARK G; FINLAND M
Comparative activity of various penicillins against penicillinase-producing and nonpenicillinase-producing staphylococci.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1961;106():78-85.
1961: KUNIN C M; FINLAND M
Clinical pharmacology of the tetracycline antibiotics.
Clinical pharmacology and therapeutics 1961;2():51-69.
1960: LERNER A M; KLEIN J O; LEVIN H S; FINLAND M
Infections due to Coxsackie virus group A, type 9, in Boston, 1959, with special reference to exanthems and pneumonia.
The New England journal of medicine 1960;263():1265-72.
1960: LERNER A M; KLEIN J O; FINLAND M
A laboratory outbreak of infections with Coxsackie virus group A, type 9.
The New England journal of medicine 1960;263():1302 4.
1960: KLEIN J O; LERNER A M; FINLAND M
Acute gastroenteritis associated with ECHO virus, Type 11.
The American journal of the medical sciences 1960;240():749-53.
1960: FINLAND M; GARROD L P
Demethylchlortetracycline.
British medical journal 1960;2(5204):959-63.
1960: FINLAND M
Antibacterial agents: uses and abuses in treatment and prophylaxis.
Rhode Island medical journal 1960;43():499-504 passim.
1960: FINLAND M
Treatment of pneumonia and other serious infections.
The New England journal of medicine 1960;263():207-21.
1960: HIRSCH H A; FINLAND M
Comparative activity of four tetracycline analogues against pathogenic bacteria in vitro.
The American journal of the medical sciences 1960;239():288-94.
1960: FINLAND M; HIRSCH H A; WALLMARK G
Pathogenic staphylococci isolated at Boston City Hospital in 1958: phage types and antibiotic susceptibility.
Archives of internal medicine 1960;105():383-97.
1960: KUNIN C M; CHALMERS T C; LEEVY C M; SEBASTYEN S C; LIEBER C S; FINLAND M
Absorption of orally administered neomycin and kanamycin with special reference to patients with severe hepatic and renal disease.
The New England journal of medicine 1960;262():380-5.
1960: HIRSCH H A; McCARTHY C G; FINLAND M
Polymyxin B and colistin: activity, resistance and crossresistance in vitro.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1960;103():338-42.
1960: HIRSCH H A; FINLAND M
Antibiotic combinations: antibacterial action of serum after ingestion of novobiocin or tetracycline or both.
The New England journal of medicine 1960;262():209-14.
1960: HIRSCH H A; PRYLES C V; FINLAND M
Effect of food on absorption of a new form of erythromycin propionate.
The American journal of the medical sciences 1960;239():198-202.
1960: KUNIN C M; FINLAND M
Absorption and urinary excretion of chloramphenicol and 2 analogues, thiocymetin and U-15, 442 in normal men.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1960;103():246-50.
1960: HIRSCH H A; FINLAND M
Susceptibility of gonococci to antibiotics and sulfadiazine. A study of strains isolated at Boston City Hospital from cases of acute gonorrheal urethritis in males, August, 1958 to February, 1959.
The American journal of the medical sciences 1960;239():41-50.
1960: HIRSCH H A; FINLAND M
Susceptibility of Hemophilus influenzae to 21 antibiotics in vitro.
The American journal of the medical sciences 1960;239():33-40.
1960: MCCARTHY C G; HIRSCH H A; FINLAND M
Serum levels after single oral doses of 6-(a-phenoxypropionamido) penicillanate and penicllin V.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1960;103():117-80.
1959: KUNIN C M; FINLAND M
Restrictions imposed on antibiotic therapy by renal failure.
Archives of internal medicine 1959;104():1030-50.
1959: FINLAND M
Chemoprophylaxis of infectious diseases, I. General considerations and application to streptococcal infections, rheumatic fever, glomerulonephritis and bacterial endocarditis.
Disease-a-month : DM 1959;1959():1-40.
1959: KUNIN C M; FINLAND M
Excretion of demethylchlortetracycline into the bile.
The New England journal of medicine 1959;261():1069-71.
1959: KUNIN C M; DORNBUSH A C; FINLAND M
Distribution and excretion of four tetracycline analogues in normal young men.
The Journal of clinical investigation 1959;38():1950-63.
1959: KUNIN C M; REES S B; MERRILL J P; FINLAND M
Persistence of antibiotics in blood of patients with acute renal failure. I. Tetracycline and chlortetracycline.
The Journal of clinical investigation 1959;38():1487-97.
1959: KUNIN C M; GLAZKO A J; FINLAND M
Persistence of antibiotics in blood of patients with acute renal failure. II. Chloramphenicol and its metabolic products in the blood of patients with severe renal disease or hepatic cirrhosis.
The Journal of clinical investigation 1959;38():1498-508.
1959: KUNIN C M; FINLAND M
Persistence of antibiotics in blood of patients with acute renal failure. III. Penicillin, streptomycin, erythromycin and kanamycin.
The Journal of clinical investigation 1959;38():1509-19.
1959: FINLAND M; JONES W F; BENNETT I L
Antibiotic susceptibility and phage type of pathogenic staphylocci: a study of two hundred ten strains isolated at Boston City Hospital in 1955.
Archives of internal medicine 1959;104():365-77.
1959: HIRSCH H A; KUNIN C M; FINLAND M
[Demethylchlortetracycline. A new and more stable antibiotic of the tetracycline group with a stronger and longer-acting antibacterial effect.]
Münchener medizinische Wochenschrift (1950) 1959;101():1311-5.
1959: FINLAND M
The Staphylococcus problem and antistaphylococcal antibiotics.
GP 1959;20(1):114-22.
1959: HIRSCH H A; FINLAND M
Effect of food on the absorption of erythromycin propionate, erythromycin stearate and triacetyloleandomycin.
The American journal of the medical sciences 1959;237(6):693-709.
1959: HIRSCH H A; FINLAND M
Antibacterial activity of serum of normal subjects after oral doses of demethylchlortetracycline, chlortetracycline and oxytetracycline.
The New England journal of medicine 1959;260(22):1099-104.
1959: MARTIN C M; KUNIN C M; GOTTLIEB L S; FINLAND M
Asian influenza A in Boston, 1957-1958. II. Severe staphylococcal pneumonia complicating influenza.
A.M.A. archives of internal medicine 1959;103(4):532-42.
1959: MARTIN C M; KUNIN C M; GOTTLIEB L S; BARNES M W; LIU C; FINLAND M
Asian influenza A in Boston, 1957-1958. I. Observations in thirty-two influenza-associated fatal cases.
A.M.A. archives of internal medicine 1959;103(4):515-31.
1959: HIRSCH H A; KUNIN C M; FINLAND M
Antibacterial activity of serum of normal men after oral doses of erythromycin propionate and triacetyloleandomycin.
The New England journal of medicine 1959;260(9):408-12.
1959: KUNIN C M; SCHWARTZ R; YAFFE S; KNAPP J; FELLERS F X; JANEWAY C A; FINLAND M
Antibody response to influenza-virus vaccine in children with nephrosis: effect of cortisone.
Pediatrics 1959;23(1 Part 1):54-62.
1959: KUNIN C M; DORNBUSH A C; FINLAND M
The distribution and excretion of four tetracycline analogues in normal young men.
Antibiotics annual 1959;7():386-7.
1959: KUNIN C M; CHALMERS T G; LEEVY C M; SEBASTYEN S C; LIEBER C S; FINLAND M
Absorption of orally administered neomycin and kanamycin, with special reference to patients with severe hepatic and renal diseases.
Antibiotics annual 1959;7():489-90.
1959: FINLAND M
The challenge of new drugs to the clinical investigator.
Antibiotics annual 1959;7():21-8.
1959: FINLAND M; HIRSCH H A; KUNIN C M
Observations on demethylchlortetracycline.
Antibiotics annual 1959;7():375-82.
1958: KUNIN C M; WILCOX C; NAJARIAN A; FINLAND M
Susceptibility and crossresistance of bacteria to four related antibiotics: kanamycin, paromomycin, neomycin and streptomycin.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1958;99(2):312-6.
1958: KUNIN C M; FINLAND M
Demethylchlortetracycline; a new tetracycline antibiotic that yields greater and more sustained antibacterial activity.
The New England journal of medicine 1958;259(21):999-1005.
1958: FINLAND M
Antibiotic for staphylococcal infections.
The Medical clinics of North America 1958;42(5):1179-94.
1958: KUNIN C M; FINLAND M
Susceptibility and cross resistance of bacteria to streptomycin, neomycin, paromomycin, and kanamycin.
Annals of the New York Academy of Sciences 1958;76(2):42-3.
1958: KUNIN C M; PRYLES C V; FINLAND M
Antibacterial activity of serum after oral doses of triacetyloleandomycin, erythromycin, potassium penicillin V and penicillin V.
Pediatrics 1958;22(3):422-31.
1958: KUNIN C M; JONES W F; FINLAND M
[Enhancement of tetracycline blood levels.]
The New England journal of medicine 1958;259(4):147-56.
1958: FINLAND M
Kanamycin.
Lancet 1958;2(7039):209-11.
1958: FINLAND M
[Antibiotic blood level enhancement.]
Antibiotic medicine & clinical therapy 1958;5(6):359-63.
1958: PRYLES C V; FINLAND M
N1 acetyl sulfamethoxypyridazine: concentrations in blood and urine during oral administration and comparisons with sulfamethoxypyridazine.
The American journal of the medical sciences 1958;235(5):555-61.
1958: FINLAND M; PRYLES C V; JONES W F
Antibiotic combinations; antibacterial action of plasma of human subjects after ingestion of penicillin V or chloramphenicol or both.
The New England journal of medicine 1958;258(17):817-24.
1958: FINLAND M
Current concepts in therapy; antibiotics. III. Absorption and excretion and toxicity.
The New England journal of medicine 1958;258(11):544-6.
1958: FINLAND M
Observations on antibiotic resistance of certain pathogenic bacteria.
Transactions & studies of the College of Physicians of Philadelphia 1958;25(3):144-52.
1958: GABUZDA G J; GOCKE T M; JACKSON G G; GRIGSBY M E; DEL LOVE B; FINLAND M
Some effects of antibiotics on nutrition in man; including studies of the bacterial flora of the feces.
A.M.A. archives of internal medicine 1958;101(2):476-513.
1958: FINLAND M; BARNES M W
Cold agglutinins. VIII. Occurrence of cold isohemagglutinins in patients with primary atypical pneumonia or influenza viral infection, Boston City Hospital, June, 1950, to July, 1956.
A.M.A. archives of internal medicine 1958;101(2):462-6.
1958: FINLAND M
Current status of therapy in bacterial endocarditis.
Journal of the American Medical Association 1958;166(4):364-73.
1958: FINLAND M; FOLTZ E; GERACI J E; KIRBY W M; QUINN E L; ROMANSKY M J; YOW E M
The current status of erythromycin, kanamycin, novobiocin, oleandomycin, ristocetin, and vancomycin, with particular reference to their use in staphylococcal disease; panel discussion.
Antibiotics annual 1958;6():1051-72.
1958: KUNIN C M; HIRSCH H A; FINLAND M
Absorption of erythromycin propionate and triacetyloleandomycin.
Antibiotics annual 1958;6():382.
1958: KASS E H; FINLAND M
Corticosteroids and infections.
Advances in internal medicine 1958;9():45-80.
1957: JONES W F; FINLAND M
Antibiotic combinations; antibacterial action of plasma after ingestion of novobiocin or penicillin G or both.
The New England journal of medicine 1957;257(26):1268-74.
1957: ZIAI M; FINLAND M
Placental transfer of sulfamethoxypyridazine.
The New England journal of medicine 1957;257(24):1180-1.
1957: FINLAND M; JONES W F; ZIAI M; CHERRICK G R
Sulfamethoxypyridazine: concentrations in blood and urine during oral administration of various dosages.
The American journal of the medical sciences 1957;234(5):505-16 passim.
1957: JONES W F; FINLAND M
Sulfamethoxypyridazine and sulfachloropyridazine.
Annals of the New York Academy of Sciences 1957;69(3):473-84.
1957: JONES W F; FINLAND M
Antibiotic combinations: antistreptococcal and anti-staphylococcal activity of normal subjects after ingestion of erythromycin or chloramphenicol or both.
The New England journal of medicine 1957;257(16):744-8.
1957: JONES W F; FINLAND M
Antibiotic combinations; tetracycline, erythromycin, oleandomycin and spiramycin and combinations of tetracycline with each of the other three agents; comparisons of activity in vitro and antibacterial action of blood after oral administration.
The New England journal of medicine 1957;257(12):536-47 concl.
1957: JONES W F; FINLAND M
Antibiotic combinations; tetracycline, erythromycin, oleandomycin and spiramycin, and combinations of tetracycline with each of the other three agents; comparisons of activity in vitro and antibacterial action of blood after oral administration.
The New England journal of medicine 1957;257(11):481-91 contd.
1957: JONES W F; ZIAI M; CHERRICK G R; FINLAND M
Absorption and excretion of sulfachloropyridazine.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1957;95(4):642-5.
1957: FINLAND M; NICHOLS R L
Current therapeutics. CXIV. Novobiocin.
The Practitioner 1957;179(1069):84-92.
1957: JONES W F; FINLAND M
Antibiotic combinations: antibacterial action of plasma of normal subjects after oral doses of penicillin V, tetracycline hydrochloride and a combination of both.
The New England journal of medicine 1957;256(19):869-75.
1957: JONES W F; FINLAND M
Susceptibility of enterococci and of hemolytic streptococci of groups A, B, C, and G to five new antibiotics in vitro.
American journal of clinical pathology 1957;27(5):528-33.
1957: FINLAND M
Staphylococci, antibiotics, and endocarditis.
Circulation 1957;15(5):641-5.
1957: JONES W F; FINLAND M
Susceptibility of enterococcus to eleven antibiotics in vitro; with special reference to species differences.
American journal of clinical pathology 1957;27(4):467-81.
1957: JONES W F; FINLAND M
Susceptibility of enterococcus to eleven antibiotics in vitro; with special reference to species differences.
Technical bulletin of the Registry of Medical Technologists 1957;27(3):49-63.
1957: NICHOLS R L; FINLAND M
Absorption and excretion of sulfamethoxypyridazine: a new, long-acting antibacterial sulfonamide.
The Journal of laboratory and clinical medicine 1957;49(3):410-21.
1957: JONES W F; FINLAND M
Susceptibility of pneumococci to eleven antibiotics in vitro.
The American journal of the medical sciences 1957;233(3):312-9.
1957: NICHOLS R L; RICHARDS W A; FINLAND M
Penicillin and probenecid: a controlled study of penicillin levels in plasma of patients with bacterial endocarditis.
The American journal of the medical sciences 1957;233(3):245-55.
1957: JONES W F; FELDMAN H A; FINLAND M
Susceptibility of hemolytic streptococci, other than those of group D, to eleven antibiotics in vitro.
American journal of clinical pathology 1957;27(2):159-69.
1957: FINLAND M; JONES W F
Antibiotic combinations; antistreptococcal and antistaphylococcal activity of plasma of normal subjects after oral doses of penicillin, oleandomycin and combinations of these antibiotics.
The New England journal of medicine 1957;256(3):115-9.
1957: BARNES M W; FINLAND M
Characterization of strains of influenza virus isolated in Boston in 1943-1944.
The Journal of laboratory and clinical medicine 1957;49(1):19-30.
1957: FINLAND M
The new antibiotic era: for better or for worse?
Antibiotic medicine & clinical therapy 1957;4(1):17-20.
1957: FINLAND M
[Prevention of acute articular rheumatism. A. Problems created by the systematic administration of antibiotics.]
Revue du rhumatisme et des maladies ostéo-articulaires 1957;24(Special No):67-8.
1957: KASS E H; FINLAND M
Adrenocortical hormones and the management of infection.
Annual review of medicine 1957;8():1-18.
1956: FINLAND M; GIALDRONI-GRASSI G; PRYLES C V
A controlled study of the use of prophylactic antimicrobials in premature infants; bacteriologic observations.
Pediatrics 1956;18(6):899-917.
1956: FINLAND M; JONES W F; NICHOLS R L
Development of resistance and cross-resistance in vitro to erythromycin, carbomycin, spiramycin, oleandomycin and streptogramin.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1956;93(2):388-93.
1956: FINLAND M; JONES W F
Antibiotic combinations; antistreptococcal and antistaphylococcal activity of plasms of normal subjects after ingestion of erythromycin or penicillin or both.
The New England journal of medicine 1956;255(22):1019-24.
1956: BARNES M W; FINLAND M; PRYLES C V
Influenza in Boston during the winter of 1955.
American journal of hygiene 1956;64(3):289-303.
1956: FINLAND M; JONES W F
Clinical staphylococcal infections; staphylococcal infections currently encountered in a large municipal hospital: some problems in evaluating antimicrobial therapy in such infections.
Annals of the New York Academy of Sciences 1956;65(3):191-205.
1956: FINLAND M; JONES W F; NICHOLS R L
Sulfamethoxypyridazine: preliminary observations on absorption and excretion of a new, long-acting antibacterial sulfonamide.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1956;92(3):637-40.
1956: JONES W F; NICHOLS R L; FINLAND M
Antibacterial activity of streptonivicin and cathomycin, two new antibiotics.
The Journal of laboratory and clinical medicine 1956;47(5):783-92.
1956: ALTEMEIER W A; DOWLING H F; FINLAND M; KIRBY W M; PULASKI E J; SANDUSKY W; WISE N; MONCRIEF J
Susceptibility of microorganisms to antibiotics isolated from hospitalized and nonhospitalized persons; panel discussion.
Antibiotics annual 1956;():1089-109.
1955: NICHOLS R L; JONES W F; FINLAND M
Plasma penicillin levels from oral penicillins V and G and intramuscular penicillin G.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1955;90(3):688-92.
1955: FINLAND M
Emergence of antibiotic-resistant bacteria.
The New England journal of medicine 1955;253(23):1019-28; concl.
1955: FINLAND M
Emergence of antibiotic-resistant bacteria.
The New England journal of medicine 1955;253(22):969-79; contd.
1955: FINLAND M
Emergence of antibiotic-resistant bacteria.
The New England journal of medicine 1955;253(21):909-22; contd.
1955: FINLAND M
Present status of tests for sensitivity of bacteria to antimicrobial agents.
American journal of clinical pathology 1955;25(11):1333-5.
1955: JONES W F; FINLAND M
Blood levels from orally administered penicillins G and V; relation to food intake.
The New England journal of medicine 1955;253(18):754-61.
1955: FINLAND M; BARNES M W
Influenza A in Boston, 1951 and 1953; isolation of virus and serological studies in patients, including a study of antigenic relationships among strains of influenza A virus isolated in Boston from 1943 through 1953.
American journal of hygiene 1955;62(1):1-20.
1955: FINLAND M; BARNES M W
Laboratory experiences with influenza in Boston during the winter 1949-50.
The Journal of infectious diseases 1955;97(1):48-56.
1955: FINLAND M
Antibiotic-resist micrococcic infections: guest editorial.
Journal of the American Medical Association 1955;158(3):188-90.
1955: FINLAND M
Introductory remarks on the current status of antibiotic therapy and the outlook for future developments.
The American journal of medicine 1955;18(5):679-85.
1955: FINLAND M
Changing patterns of resistance of certain pathogenic bacteria to antimicrobial agents.
The New England journal of medicine 1955;252(14):570-80.
1955: FINLAND M
Therapy of influenzal meningitis.
Antibiotic medicine & clinical therapy 1955;1(3):123-4; Spanish transl, 175-6.
1955: FINLAND M
Antimicrobial therapy of meningococcal infections.
Antibiotic medicine & clinical therapy 1955;1(3):122-3; Spanish transl, 174-5.
1955: FINLAND M; BARNES M W
Influenza B in Boston, 1952; isolations of virus and serologic studies in patients, including a study of antigenic differences among influenza B viruses isolated in Boston from 1945 to 1952.
American journal of hygiene 1955;61(1):24-39.
1955: LOVE B D; FINLAND M
Susceptibility of Neisseria gonorrhoeae to eleven antibiotics and sulfadiazine; comparison of susceptibility of recently isolated strains with results obtained in previous years in the same laboratory.
A.M.A. archives of internal medicine 1955;95(1):66-73.
1955: FINLAND M
Discussion of papers on cathomycin.
Antibiotics annual 1955;3():929.
1954: DEL LOVE B; FINLAND M
Susceptibility of recently isolated strains of hemophilus influenzae to eleven antibiotics in vitro.
The Journal of pediatrics 1954;45(5):531-7.
1954: LOVE B D; FINLAND M
In vitro susceptibility of meningococci to eleven antibiotics and sulfadiazine.
The American journal of the medical sciences 1954;228(5):534-9.
1954: FINLAND M
[Antibiotic spectra of pathogenic bacteria.]
Medicina 1954;14(5):307-29.
1954: WRIGHT S S; POTEE K G; FINLAND M
Susceptibility of Pseudomonas to ten antibiotics in vitro: some properties of recently isolated strains.
American journal of clinical pathology 1954;24(10):1121-32.
1954: POTEE K G; WRIGHT S S; FINLAND M
In vitro susceptibility of recently isolated strains of Proteus to ten antibiotics.
The Journal of laboratory and clinical medicine 1954;44(3):463-77.
1954: JACKSON G G; GABUZDA G J; FINLAND M
Effect of antibiotics on organisms used in certain microbiologic assays of essential nutrients.
The Journal of laboratory and clinical medicine 1954;44(3):449-62.
1954: FINLAND M
Treatment of bacterial endocarditis.
The New England journal of medicine 1954;250(10):419-28; concl.
1954: FINLAND M
Treatment of bacterial endocarditis.
The New England journal of medicine 1954;250(9):372-83; contd.
1954: FINLAND M
[Pneumonia: current status of diagnosis and therapy.]
Anais paulistas de medicina e cirurgia 1954;67(2):91-111.
1954: FINLAND M
Treatment of bacterial endocarditis; dosage of penicillin, use of other antibiotics and treatment of patients with negative blood cultures.
Circulation 1954;9(2):292-9.
1954: FINLAND M; PURCELL E M; WRIGHT S S; LOVE B D; MOU T W; KASS E H
Clinical and laboratory observations of a new antibiotic, tetracycline.
Journal of the American Medical Association 1954;154(7):561-8.
1954: FINLAND M
Pneumonia: present status of diagnosis and treatment.
Journal of the Indian Medical Association 1954;23(4):161-9.
1954: WRIGHT S S; PURCELL E M; WILCOX C; BRODERICK M K; FINLAND M
Antibiotic combinations and resistance: response of E. coli to antibiotics, singly and in pairs.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1954;85(1):128-33.
1954: PURCELL E M; WRIGHT S S; MOU T W; FINLAND M
Blood levels and urinary excretion in normal subjects after ingestion of tetracycline analogues.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1954;85(1):61-5.
1954: WRIGHT S S; FINLAND M
Cross-resistance among 3 tetracyclines.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1954;85(1):40-2.
1954: LOVE B D; WRIGHT S S; PURCELL E M; MOU T W; FINLAND M
Antibacterial action of tetracycline: comparisons with oxytetracycline and chlortetracycline.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1954;85(1):25-9.
1954: FINLAND M; GRIGSBY M E; HAIGHT T H
Efficacy and toxicity of oxytetracycline (terramycin) and chlortetracycline (aureomycin); with special reference to use of doses of 250 mg. every four to six hours and to occurrence of staphylococcic diarrhea.
A.M.A. archives of internal medicine 1954;93(1):23-43.
1953: FINLAND M; WRIGHT S S
Current therapeutics. LXXII. Bacitracin.
The Practitioner 1953;171(1026):660-72.
1953: WRIGHT S S; PURCELL E M; WILCOX C; BRODERICK M K; FINLAND M
Antibiotic combinations and resistance to antibiotics; development of resistance during repeated subcultures of Staphylococci and certain Streptococci on media containing penicillin, streptomycin, erythromycin, terramycin, and chloramphenicol used singly and in pairs.
The Journal of laboratory and clinical medicine 1953;42(6):877-95.
1953: FINLAND M
Clinical uses of currently available antibiotics.
British medical journal 1953;2(4846):1115-21.
1953: WRIGHT S S; PURCELL E M; KASS E H; FINLAND M
Penicillin G and benzethacil by mouth: comparison of penicillin levels in plasma of normal men after single oral doses.
The Journal of laboratory and clinical medicine 1953;42(3):417-29.
1953: FINLAND M
Pneumonia: present status of diagnosis and treatment.
South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 1953;27(33):694-700.
1953: KASS E H; LUNDGREN M M; FINLAND M
Observations on the effect of corticosteroids and growth hormone on resistance to experimental pneumococcal and influenza virus infections.
Annals of the New York Academy of Sciences 1953;56(4):765-71.
1953: FINLAND M; WILCOX C
Antibiotic combinations and resistance to antibiotics: penicillin with other antibiotics against penicillin-resistant staphylococci.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1953;83(3):605-8.
1953: FINLAND M
[Pneumonia; current status of diagnosis and therapy.]
Archivos médicos de Cuba 1953;4(2):194-205.
1953: FINLAND M; WEINSTEIN L
Complications induced by antimicrobial agents.
The New England journal of medicine 1953;248(6):220-6.
1953: FINLAND M; HAIGHT T H
Antibiotic resistance of pathogenic staphylococci; study of five hundred strains isolated at Boston City Hospital from October, 1951, to February, 1952.
A.M.A. archives of internal medicine 1953;91(2):143-58.
1953: PURCELL E M; WRIGHT S S; FINLAND M
Antibiotic combinations and resistance to antibiotics; penicillin-erythromycin and streptomycin-erythromycin combinations in vitro.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1953;82(1):124-31.
1952: FINLAND M; WILCOX C; WRIGHT S S; PURCELL E M
Cross resistance to antibiotics: effect of exposures of bacteria to carbomycin or erythromycin in vitro.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1952;81(3):725-9.
1952: HAIGHT T H; FINLAND M
Observations on mode of action of erythromycin.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1952;81(1):188-93.
1952: HAIGHT T H; FINLAND M
Resistance of bacteria to erythromycin.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1952;81(1):183-8.
1952: HAIGHT T H; FINLAND M
The antibacterial action of erythromycin.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1952;81(1):175-83.
1952: FINLAND M
Pneumonia: present status of diagnosis and treatment.
Cyprus medical journal 1952;5(11-12):899-916.
1952: FINLAND M
Antibiotic treatment of viral diseases.
The Medical clinics of North America 1952;36(5):1239-52.
1952: FINLAND M
Antimicrobial treatment for viral and related infections. I. Antibiotic treatment of primary atypical pneumonia.
The New England journal of medicine 1952;247(9):317-25.
1952: HAIGHT T H; FINLAND M
Laboratory and clinical studies on erythromycin.
The New England journal of medicine 1952;247(7):227-32.
1952: HAIGHT T H; FINLAND M
Modified Gots test for penicillinase production.
American journal of clinical pathology 1952;22(8):806-8.
1952: HAIGHT T H; WILCOX C; FINLAND M
Cross-resistance to antibiotics; effect of repeated exposures of bacteria to streptomycin or neomycin on the resistance to both of these and to six other antibiotics.
The Journal of laboratory and clinical medicine 1952;39(4):637-48.
1952: KASS E H; AYCOCK R R; FINLAND M
Clinical evaluation of aureomycin and chloramphenicol in herpes zoster.
The New England journal of medicine 1952;246(5):167-72.
1951: JACKSON G G; HAIGHT T H; KASS E H; WOMACK C R; GOCKE T M; FINLAND M
Terramycin therapy of pneumonia: clinical and bacteriologic studies in 91 cases.
Annals of internal medicine 1951;35(6):1175-1202.
1951: KASS E H; GEIMAN Q M; FINLAND M
Effects of ACTH on induced malaria in man.
The New England journal of medicine 1951;245(26):1000-2.
1951: GOCKE T M; FINLAND M
Crossresistance to antibiotics; effect of repeated exposure of bacteria to aureomycin, terramycin, chloramphenicol or neomycin on the resistance to all of these antibiotics and to streptomycin and penicillin.
The Journal of laboratory and clinical medicine 1951;38(5):719-35.
1951: JACKSON G G; FINLAND M
Comparison of methods for determining sensitivity of bacteria to antibiotics in vitro.
A.M.A. archives of internal medicine 1951;88(4):446-60.
1951: JACKSON G G; FINLAND M
Turbidimetric method for determining sensitivity of bacteria to antibiotics.
The Journal of laboratory and clinical medicine 1951;38(2):289-307.
1951: KASS E H; FINLAND M
The role of steroids in infection and immunity.
Pediatrics 1951;8(1):137-8.
1951: HAZEN L N; JACKSON G G; CHANG S M; PLACE E H; FINLAND M
Antibiotic treatment of pertussis; comparison of penicillin, aureomycin, chloramphenicol, and terramycin in 150 cases.
The Journal of pediatrics 1951;39(1):1-15.
1951: KASS E H; INGBAR S H; LUNDGREN M M; FINLAND M
The effect of ACTH and cortisone on pneumococcal and influenza viral infections in the white mouse.
The Journal of laboratory and clinical medicine 1951;37(5):780-8.
1951: FINLAND M
The present status of antibiotics in bacterial infections.
Bulletin of the New York Academy of Medicine 1951;27(4):199-220.
1951: KASS E H; NEVA F A; FINLAND M
Failure of ACTH to protect against acutely lethal toxins of influenza virus and rickettsiae.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1951;76(3):560-3.
1951: KASS E H; LUNDGREN M M; FINLAND M
Effect of ACTH on leucocyte counts in white mice.
The Journal of laboratory and clinical medicine 1951;37(3):458-63.
1951: KASS E H; FINLAND M
The role of adrenal steroids in infection and immunity.
The New England journal of medicine 1951;244(13):464-70.
1951: FINLAND M; BARNES M W
Cold agglutinins. VII. tests for cold isohemagglutinins in pneumonia and other acute respiratory infections over a four-year period.
The American journal of the medical sciences 1951;221(2):152-7.
1951: NEVA F A; NELSON R J; FINLAND M
Hospital outbreak of infections with Salmonella newington.
The New England journal of medicine 1951;244(7):252-5.
1951: FINLAND M; BARNES M W; WELLS E B
Influenza viral infections in Boston, September 1947 to August 1949; a study of the serologic response of patients and of the antigenic differences among the influenza viruses that were isolated.
The Journal of laboratory and clinical medicine 1951;37(1):88-103.
1951: FINLAND M; JACKSON G G; KASS E H; HAIGHT T H; WOMACK C R
Some recent observations on staphylococcal infections in relation to antibiotic therapy.
Transactions of the Association of American Physicians 1951;64():343-4.
1950: KASS E H; LUNDGREN M M; FINLAND M
Failure of aureomycin and terramycin to increase resistance to toxic action of influenza virus.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1950;75(2):520-3.
1950: JACKSON G G; CHANG S M; PLACE E H; FINLAND M
Sensitivity of diphtheria bacilli and related organisms to nine antibiotics.
The Journal of pediatrics 1950;37(5):718-26.
1950: KASS E H; INGBAR S H; FINLAND M
Effects of adrenocorticotropic hormone in pneumonia: clinical, bacteriological and serological studies.
Annals of internal medicine 1950;33(5):1081-98.
1950: KASS E H; FINLAND M
Effect of ACTH on induced fever.
The New England journal of medicine 1950;243(18):693-5.
1950: JACKSON G G; BARNES M W; FINLAND M
Comparison of seven antibiotics against Hemophilus pertussis infection in chick embryos.
Journal of immunology (Baltimore, Md. : 1950) 1950;65(4):419-24.
1950: WOMACK C R; KASS E H; FINLAND M
Further observations on a substance in egg yolk which protects aureomycin from deterioration.
The Journal of laboratory and clinical medicine 1950;36(4):655-9.
1950: JACKSON G G; SHIH-MAN C; BARNES M W; FINLAND M
Terramycin in pertussis: clinical and laboratory studies.
Annals of the New York Academy of Sciences 1950;53(2):422-6.
1950: KASS E H; BARNES M W; FINLAND M
Terramycin in influenza viral infections.
Annals of the New York Academy of Sciences 1950;53(2):412-21.
1950: GOCKE T M; JACKSON G G; WILCOX C; FINLAND M
In vitro studies on terramycin.
Annals of the New York Academy of Sciences 1950;53(2):297-302.
1950: FINLAND M; GOCKE T M; JACKSON G G; WOMACK C R; KASS E H
Clinical studies on terramycin.
Annals of the New York Academy of Sciences 1950;53(2):290-6.
1950: GOCKE T M; FINLAND M
Development of chloramphenicol-resistant and chloramphenicol-dependent variants of a strain of Klebsiella pneumoniae.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1950;74(4):824-9.
1950: FINLAND M; WELLS E B
The antibiotics in gastrointestinal diseases.
The Review of gastroenterology 1950;17(7):558-62.
1950: JACKSON G G; GOCKE T M; COLLINS H S; FINLAND M
In vitro sensitivity of pathogenic enteric bacteria to various antibiotics.
The Journal of infectious diseases 1950;87(1):63-70.
1950: GOCKE T M; WELLS E B; COLLINS H S; FINLAND M
Blood levels and urinary excretion of aureomycin after intravenous and intramuscular administration.
The Journal of laboratory and clinical medicine 1950;36(1):100-12.
1950: WELLS E B; SHIH-MAN C; JACKSON G G; FINLAND M
Antibiotic spectrum of Hemophilus pertussis.
The Journal of pediatrics 1950;36(6):752-7.
1950: GOCKE T M; WILCOX C; FINLAND M
Antibiotic spectrum of the gonococcus.
American journal of syphilis, gonorrhea, and venereal diseases 1950;34(3):265-72.
1950: FINLAND M; WILCOX C
In vitro susceptibility of Hemophilus influenzae to seven antibiotics.
American journal of clinical pathology 1950;20(4):335-40.
1950: FINLAND M; FRANK P F; WILCOX C
In vitro susceptibility of pathogenic staphylococci to seven antibiotics.
American journal of clinical pathology 1950;20(4):325-34.
1950: KASS E H; INGBAR S H; FINLAND M
Renal glycosuria induced by adrenocorticotrophic hormone.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1950;73(4):669-72.
1950: JACKSON G G; GOCKE T M; WILCOX C; FINLAND M
In vitro susceptibility of pneumococci to seven antibiotics.
American journal of clinical pathology 1950;20(3):218-24.
1950: FINLAND M; WILCOX C; FRANK P F
In vitro sensitivity of human pathogenic strains of streptococci to seven antibiotics.
American journal of clinical pathology 1950;20(3):208-17.
1950: FRANK P F; WILCOX C; FINLAND M
In vitro sensitivity of Bacillus proteus and Pseudomonas aeruginosa to seven antibiotics; penicillin, streptomycin, bacitracin, polymyxin, aerosporin, aureomycin, and chloromycetin.
The Journal of laboratory and clinical medicine 1950;35(2):205-14.
1950: FRANK P F; WILCOX C; FINLAND M
In vitro sensitivity of coliform bacilli to seven antibiotics; penicillin, streptomycin, bacitracin, polymyxin, aerosporin, aureomycin, and chloromycetin.
The Journal of laboratory and clinical medicine 1950;35(2):188-204.
1950: FINLAND M; WELLS E B
Aureomycin in the treatment of influenza and certain other acute respiratory infections with or without pneumonia.
The American journal of medicine 1950;8(1):21-30.
1949: FINLAND M; FINNERTY E F
Aureomycin treatment of herpes zoster.
The New England journal of medicine 1949;241(26):1037-47.
1949: COLLINS H S; GOCKE T M; FINLAND M
Aureomycin therapy of nonpneumococcic and nontuberculous bacterial pulmonary infections.
Archives of internal medicine (Chicago, Ill. : 1908) 1949;84(6):875-90.
1949: GOCKE T M; COLLINS H S; FINLAND M
Aureomycin treatment of pneumococcic pneumonia; clinical and laboratory studies on 33 patients.
Archives of internal medicine (Chicago, Ill. : 1908) 1949;84(6):857-74.
1949: WELLS E B; FINLAND M
Comparative effect of aureomycin and chloromycetin on psittacosis infection in chick embryos.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1949;72(2):365-8.
1948: FINLAND M; COLLINS H S; PAINE T F
Aureomycin, a new antibiotic; results of laboratory studies and of clinical use in 100 cases of bacterial infections.
Journal of the American Medical Association 1948;138(13):946-9.
1948: PAINE T F; COLLINS H S; FINLAND M
Bacteriologic studies on aureomycin.
Journal of bacteriology 1948;56(4):489-97.
1948: MORGAN H R; BARNES M W; FINLAND M
Antigenic differences among influenza A viruses, including serologic response of patients.
The Journal of laboratory and clinical medicine 1948;33(10):1212-9.
1948: Paine T F; Collins H S; Finland M
Bacteriologic Studies on Aureomycin.
Journal of bacteriology 1948;56(4):489-97.
1948: PAINE T F; FINLAND M
Observations on bacteria sensitive to, resistant to, and dependent upon streptomycin.
Journal of bacteriology 1948;56(2):207-18.
1948: MORGAN H R; FINLAND M
Serologic findings in patients with primary atypical pneumonia.
American journal of clinical pathology 1948;18(8):593-7.
1948: Paine T F; Finland M
Observations on Bacteria Sensitive to, Resistant to, and Dependent upon Streptomycin.
Journal of bacteriology 1948;56(2):207-18.
1948: MORGAN H R; FINLAND M
Simplified technique for titrating influenza virus neutralizing antibody in the chick embryo.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1948;68(3):618.
1948: FINLAND M
Some aspects of the use of chemotherapy and antibiotics.
Cincinnati journal of medicine 1948;29(6):317-28.
1948: FINLAND M; JOLLIFFE L S; PARKER F
Pneumonia and erythema multiforme exudativum; report of four cases and three autopsies.
The American journal of medicine 1948;4(4):473-92.
1948: BARNES M W; MORGAN H R; FINLAND M
Isolation and identification of influenza viruses during the epidemic of December, 1945.
The Journal of laboratory and clinical medicine 1948;33(3):309-18.
1948: MURRAY R; FINLAND M
Effect of pH on streptomycin activity.
American journal of clinical pathology 1948;18(3):247-52.
1948: FINLAND M
Chemotherapy and antibiotics.
The New Orleans medical and surgical journal 1948;100(8):345-58.
1948: FINLAND M; ORY E M
Influenza and pneumonia; serologic studies during and after an outbreak of influenza B.
The Journal of laboratory and clinical medicine 1948;33(1):32-46.
1948: FINLAND M; BARNES M W
Serologic studies of influenza made in Boston during the winter of 1945-1946.
The Journal of laboratory and clinical medicine 1948;33(1):15-31.
1947: PARKER F; JOLLIFFE L S; FINLAND M
Primary atypical pneumonia; report of eight cases with autopsies.
Archives of pathology 1947;44(6):581-608.
1945: Finland M; Samper B A; Barnes M W
COLD AGGLUTININS. VI. AGGLUTININS FOR AN INDIFFERENT STREPTOCOCCUS IN PRIMARY ATYPICAL PNEUMONIA AND IN OTHER CONDITIONS AND THEIR RELATION TO COLD ISOHEMAGGLUTININS.
The Journal of clinical investigation 1945;24(4):497-502.
1945: Finland M; Barnes M W
COLD AGGLUTININS. V. DETERIORATION OF COLD ISOHEMAGGLUTININS ON STORAGE.
The Journal of clinical investigation 1945;24(4):490-6.
1945: Finland M; Samper B A; Barnes M W; Stone M B
COLD AGGLUTININS. IV. CRITICAL ANALYSIS OF CERTAIN ASPECTS OF THE METHOD FOR DETERMINING COLD ISOHEMAGGLUTININS.
The Journal of clinical investigation 1945;24(4):483-9.
1945: Finland M; Peterson O L; Barnes M W; Stone M B
COLD AGGLUTININS. III. OBSERVATIONS ON CERTAIN SEROLOGICAL AND PHYSICAL FEATURES OF COLD AGGLUTININS IN CASES OF PRIMARY ATYPICAL PNEUMONIA AND OF HEMOLYTIC ANEMIA.
The Journal of clinical investigation 1945;24(4):474-82.
1945: Finland M; Peterson O L; Allen H E; Samper B A; Barnes M W
COLD AGGLUTININS. II. COLD ISOHEMAGGLUTININS IN PRIMARY ATYPICAL PNEUMONIA OF UNKNOWN ETIOLOGY WITH A NOTE ON THE OCCURRENCE OF HEMOLYTIC ANEMIA IN THESE CASES.
The Journal of clinical investigation 1945;24(4):458-73.
1945: Finland M; Peterson O L; Allen H E; Samper B A; Barnes M W; Stone M B
COLD AGGLUTININS. I. OCCURRENCE OF COLD ISOHEMAGGLUTININS IN VARIOUS CONDITIONS.
The Journal of clinical investigation 1945;24(4):451-7.
1945: Finland M; Barnes M W; Samper B A
INFLUENZA VIRUS ISOLATIONS AND SEROLOGICAL STUDIES MADE IN BOSTON DURING THE WINTER OF 1943-1944.
The Journal of clinical investigation 1945;24(2):192-208.
1943: Peterson O L; Goodwin R A; Finland M
OBSERVATIONS ON THE URINARY EXCRETION OF SULFADIAZINE.
The Journal of clinical investigation 1943;22(5):659-72.
1941: Strauss E; Lowell F C; Finland M
OBSERVATIONS ON THE INHIBITION OF SULFONAMIDE ACTION BY PARA-AMINOBENZOIC ACID.
The Journal of clinical investigation 1941;20(2):189-97.
1940: Lowell F C; Spring W C; Finland M
BACTERICIDAL ACTION OF SODIUM SULFAPYRIDINE AND OF A GLUCOSE-SULFAPYRIDINE SOLUTION IN HUMAN BLOOD.
The Journal of clinical investigation 1940;19(1):215-8.
1940: Taylor F H; Lowell F C; Adams M A; Spring W C; Finland M; Marean N E
A COMPARATIVE STUDY OF THE BLOOD CONCENTRATIONS AND URINARY EXCRETION OF SULFAPYRIDINE AND SULFANILAMIDE AFTER SINGLE DOSES OF SULFAPYRIDINE AND RELATED COMPOUNDS ADMINISTERED BY VARIOUS ROUTES.
The Journal of clinical investigation 1940;19(1):201-13.
1940: Finland M; Spring W C; Lowell F C
IMMUNOLOGICAL STUDIES ON PATIENTS WITH PNEUMOCOCCIC PNEUMONIA TREATED WITH SULFAPYRIDINE.
The Journal of clinical investigation 1940;19(1):179-99.
1940: Spring W C; Lowell F C; Finland M
STUDIES ON THE ACTION OF SULFAPYRIDINE ON PNEUMOCOCCI.
The Journal of clinical investigation 1940;19(1):163-77.
1939: Finland M; Brown J W
IMMUNOLOGICAL STUDIES IN PATIENTS WITH PNEUMOCOCCUS TYPE III PNEUMONIA TREATED WITH SUL-FANILAMIDE AND SERUM.
The Journal of clinical investigation 1939;18(3):307-17.
1938: Finland M; Brown J W
REACTIONS OF HUMAN SUBJECTS TO THE INJECTION OF PURIFIED TYPE SPECIFIC PNEUMOCOCCUS POLYSACCHARIDES.
The Journal of clinical investigation 1938;17(4):479-88.
1936: Finland M; Tilghman R C
BACTERIOLOGICAL AND IMMUNOLOGICAL STUDIES IN FAMILIES WITH PNEUMOCOCCIC INFECTIONS: THE DEVELOPMENT OF TYPE-SPECIFIC ANTIBODIES IN HEALTHY CONTACT CARRIERS.
The Journal of clinical investigation 1936;15(5):501-8.
1936: Tilghman R C; Finland M
PNEUMOCOCCIC INFECTIONS IN FAMILIES.
The Journal of clinical investigation 1936;15(5):493-9.
1935: Ruegsegger J M; Finland M
THE INFLUENCE OF DOSAGE AND ROUTE OF INJECTION ON THE ANTIBODY RESPONSE OF HUMAN SUBJECTS TO THE SPECIFIC CARBOHYDRATE OF THE TYPE VIII PNEUMOCOCCUS.
The Journal of clinical investigation 1935;14(6):833-6.
1935: Finland M; Ruegsegger J M
IMMUNIZATION OF HUMAN SUBJECTS WITH THE SPECIFIC CARBOHYDRATES OF TYPE III AND THE RELATED TYPE VIII PNEUMOCOCCUS.
The Journal of clinical investigation 1935;14(6):829-32.
1935: Finland M; Ruegsegger J M; Felton L D
HETEROPHILE ANTIBODIES IN PNEUMONIA.
The Journal of clinical investigation 1935;14(5):683-90.
1934: Finland M; Winkler A W
ANTIBODY RESPONSE TO INFECTIONS WITH TYPE II AND THE RELATED TYPE V PNEUMOCOCCUS.
The Journal of clinical investigation 1934;13(1):97-107.
1934: Finland M; Winkler A W
ANTIBODY RESPONSE TO INFECTIONS WITH TYPE III AND THE RELATED TYPE VIII PNEUMOCOCCUS.
The Journal of clinical investigation 1934;13(1):79-95.
1934: Winkler A W; Finland M
ANTIBODY RESPONSE TO INFECTIONS WITH THE NEWLY CLASSIFIED TYPES OF PNEUMOCOCCI (COOPER).
The Journal of clinical investigation 1934;13(1):109-20.

Sign-in to see more